WuXi PharmaTech Set For Sales Synergy with U.S. Subsidiary AppTec

BEIJING - WuXi PharmaTech, one of China's fastest-growing contract research organizations in the pharmaceutical and medical device sectors, is laying the groundwork to boost earnings through cross-selling synergies with its recently acquired U.S.-based biologics firm AppTec Laboratory Services